Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group (iMig).

Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura that presents unique radiologic challenges with regards to accurate and reproducible assessment of disease extent at staging and follow-up imaging. By optimizing and harmonizing technical approaches to imaging MPM, the best quality imaging can be achieved for individual patient care, clinical trials and imaging research. This consensus statement represents agreement on harmonized, standard practices for routine multi-modality imaging of MPM, including radiography, computed tomography (CT), F-2-deoxy-D-glucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI), by an international panel of experts in the field of pleural imaging assembled by the International Mesothelioma Interest Group (iMig). In addition, modality-specific technical considerations and future directions are discussed. A bulleted summary of all technical recommendations is provided.